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Abstract
Objectives This study aims to investigate the prognostic
value of incidental aortic valve calcification (AVC), mitral
valve calcification (MVC) and mitral annular calcification
(MAC) for cardiovascular events and non-rheumatic valve
disease in particular on routine diagnostic chest CT.
Methods The study followed a case-cohort design. 10410
patients undergoing chest CT were followed for a median
period of 17 months. Patients referred for cardiovascular
disease were excluded. A random sample of 1285 subjects
and the subjects who experienced an endpoint were graded for
valve calcification by three reviewers. Cox-proportional hazard
analysis was performed to evaluate the prognostic value.
Results 515 cardiovascular events were ascertained. Com-
pared with patients with no valve calcification, patients with
severe AVC, MVC or MAC had respectively 2.03 (1.48–
2.78), 2.08 (1.04–4.19) and 1.53 (1.13–2.08) increased risks
of experiencing an event during follow-up. For valve
endpoints the hazard ratios were respectively 14.57 (5.19–
40.53), 8.78 (2.33–33.13) and 2.43 (1.18–4.98).
Conclusion Incidental heart valve calcification, detected on
routine chest CT is an independent predictor of future
cardiovascular events. The study emphasises how inciden-
tal imaging findings can contribute to clinical care. It is a
step in the process of composing an evidence-based
approach in the reporting of incidental subclinical findings.
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Abbreviations
AVC Aortic Valve Calcification
AVL Aortic Valve Leaflet
CHD Coronary Heart Disease
CI Confidence Interval
CT Computed Tomography
CVD Cardiovascular Disease
FOV Field of View
MAC Mitral Annular Calcification
MVC Mitral Valve Calcification
MVL Mitral Valve Leaflet
PAOD Peripheral Arterial Obstructive Disease
PROVIDI Prognostic Value of Unrequested Information
in Diagnostic Imaging
Introduction
Multidetector chest Computed Tomography (CT), which is
usually performed during the diagnostic work-up of
patients suffering from a variety of chest complaints, can
yield extensive additional information about the heart, the
lungs, the mediastinum, the vertebrae and the large vessels
[1]. In the last decade, the image quality of chest Computed
Tomography has improved and its usage has thereby
increased considerably. A side effect of this intense usage
is the frequent occurrence of incidental findings [2–4]. We
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detected and unrelated to the clinical indication leading to
the CT referral. Only follow-up studies can determine
whether patients can benefit from these incidental findings
as such studies uncover which incidental imaging abnor-
malities have or do not have clinically relevant prognostic
value. The latter will serve to reduce redundant additional
diagnostic work-up.
Examples of frequently encountered incidental findings
are aortic valve calcification (AVC), mitral valve calcifica-
tion (MVC) and mitral annulus calcification (MAC). These
imaging characteristics are considered to be expression of
the process of atherosclerosis [5–7] and have repeatedly
been shown to be related to cardiovascular disease (CVD),
cardiovascular death and even all-cause mortality [8–10].
However, in previous literature those image characteristics
were mainly scored on transthoracic or transoesophageal
echocardiography and to date no follow-up studies are
available that have investigated the prognostic value of
these aortic abnormalities when incidentally detected on
routine chest CT in a clinical care population. Investigating
this can provide an additional means of identifying those
patients who can benefit from timely preventative measures
[11].
The PROgnostic Value of incidental Information in
Diagnostic Imaging (PROVIDI) Study is the first longitu-
dinal study to investigate the prevalence and clinical
relevance of incidental, subclinical image characteristics in
a cohort consisting of patients with diagnostic chest CT. In
this particular study we aimed to examine whether
subclinical calcification of the aortic and mitral valve,
detected incidentally on routine diagnostic chest CT, can be
used by radiologists as independent predictors of the
occurrence of CVD and non-rheumatic valve disease in
particular. Additionally, we examine whether incidentally
detected calcified heart valves have prognostic value
beyond the hitherto typically investigated CVD markers:
aortic- and/or coronary arteries [12–16]. This study operates
from radiologist’s perspective and only seeks to incorporate
information that is readily available in routine radiological
setting. No allowance was made for the collection of
additional clinical information, such as diabetes and renal
failure, which may not routinely be available in such
settings.
Materials and methods
PROVIDI
The PROVIDI study employs a case-cohort design [17], in
cooperation with 8 participating hospitals in the Netherlands.
All patients aged 40 years and older who were referred to
one of the participating hospitals with an indication for a
chest CT between 2002 and 2005 were included (N=
23,443). Patients diagnosed with primary lung cancer
(including mesothelioma) or distant metastatic disease from
other types of cancer (excluding haematological malignan-
cies) were excluded, as it is highly unlikely that detection of
incidental imaging characteristics will alter clinical decision-
making in patients with a very poor prognosis. This resulted
in a cohort of 14,366 patients. The PROVIDI study is
approved by the Medical Ethics Committee of the Medical
Ethics Committee of the University Medical Center Utrecht,
as well as the ethical review boards of all other participating
centres. Written informed consent was waived for all patients
because of the retrospective design of this study. A privacy
protocol was implemented to protect patient’sa n o n y m i t y .
Study subjects and CT protocols
In this study patients with a CT indication directly related to
suspected cardiovascular disease were excluded (n=2303)
from the PROVIDI cohort in order to ensure that valve
calcification observed was truly incidental. Additionally, a
total of 1653 patients from a randomly chosen hospital
were excluded, to serve as an external validation sample for
future research conducted within PROVIDI. The resulting
cohort consisted of 10,410 patients. Consistent with a case-
cohort design a random sample—called subcohort—was
taken from this cohort immediately after the patients who
experienced an outcome event were ascertained to serve as
a control. It was sampled so that the resulting sample would
be at least 10% [18] of the full cohort and twice as large as
the specific group of outcome event under study, with a
reasonable margin for error (subcohort, n=1285). Figure 1
shows a flowchart of the study design and selection of the
study population.
When study subjects had more than one Chest CT
examination during follow-up, only the first Chest CT was
used. Chest CTs were obtained with 2-, 4-, 8-, 16-, 32- or
64-slice systems from different vendors. All types of
contrast enhanced CT protocols were considered eligible
as long as the field-of-view (FOV) included the heart and
the full length of the thoracic aorta. Slice thickness varied
according to the Chest CT indication and corresponding
protocol and—due to exclusion of CT examinations
performed for a cardiovascular indication—none of the
CT studies were ECG gated. Patient characteristics,
information on slice thickness and the use of a contrast
agent were abstracted from Chest CT reports by a research
physician, who also assessed the diagnostic Chest CT
indication and classified them as ‘pulmonary disease’,
‘haematological malignancy’, ‘mediastinal disease’, ‘ruled-
964 Eur Radiol (2011) 21:963–973out pulmonary malignancy’, ‘pulmonary embolism’ or ‘other
CT indications’.
Image characteristics
The CT-findings were scored for valve calcification by three
readers: one board certified radiologist with 10 years’ expe-
rience and two research physicians with two and three years’
ChestCTexperiencerespectively.Allreaderswereblindedfor
patient characteristics and outcome status. CT images were
stored in DICOM format and read using a commercially
available software program (Dicomworks, version 1.3.5). All
CTs were analysed in the axial plane; no other reformatted
planes were included for analysis. Readings were performed
using a standardised score form including information on the
type of CT protocol used and the use of contrast agent and
imaging quality. This was defined as good: clearly visible,
minimal movement artefacts, adequate: Slight blurring and/or
movement artefacts, or poor: major defects significantly
affecting visibility. These classes reflect the reliability with
which the scoring of CTcharacteristics was possible.
Calcification of the heart valves was anatomically
subdivided into calcification of the aortic valve leaflets
(AVL), the mitral valve leaflets (MVL) and the mitral
annulus. MVL calcification present as linear calcification
between the area of the left atrium and ventricle. Mitral
Annulus Calcification (0, absent; 1, present) are visible as
round or curled spots at the periphery of this horizontal
leaflet plane. AVL and MVL calcification was graded as:
grade 0, absent; grade 1, mild (one leaflet affected); grade
2, severe (2 or 3 leaflets affected), comparable to other
studies [19, 20].
Calcification was also visually assessed in the coronary
arteries and the thoracic aorta, as premature calcification in
these anatomical regions has already frequently been
related to CVD in the literature. Calcification of the aorta
was also assessed in the ascending and descending part and
in the supra-aortic arteries branching from the aortic arch.
An overall aorta score was compiled and graded as absent,
mild, moderately, or severe affected aorta. Calcification in
the coronaries was scored in a similar fashion. Both aortic
and coronary visual grading were partly comparable to a
previously described grading of coronary calcification [21].
Tables 1 and 2 provide information about the visual grading
and examples of image characteristics are presented in
Fig. 2.
Scoring was trained under the supervision of an
experienced board certified chest radiologist. The repro-
ducibility of visual grading was successfully evaluated in a
previous study [22]. Briefly, weighted kappa 0.78, 0.58,
Inclusion criteria PROVIDI
-CT Thorax 2002-2005
-> 4 0  y e r a s
5 academic hospitals 3 general hospitals
Total, N=23.443
Exclusion criteria (1)
-Primary lung cancer
-Distant metatsase from other types of 
cancer
(except haematological cancers)
Screening CT application forms Excluded
N=9.077
Full Cohort
N= 14.366
Providi General
Linkage with CBS/LMR
Exclusion criteria (2)
-Cardiovascular indication for CT
-Prior history of CVD 
Current study
CVD cases 
N=515
Subcohort 
N=1208
Exclusion  CT scans from 
randomly chosen hospital
Screening CT application forms
Excluded
N= 1653
Excluded
N=2303
Study Cohort
N= 10.410
Fig. 1 Flowchart of study design. CBS: Dutch central bureau of statistics. LMR: Dutch medical data registration
Eur Radiol (2011) 21:963–973 9650.56 and 0.87, 0.56, and 0.70 for inter- and intra observer
agreement of AVC, MVC and MAC. The weighted kappa’s
for inter- and intraobserver agreement were 0.77, 0.91 for
the coronaries, 0.72, 0.88 for the aorta and 0.89, 0.96 for
the supra aortic calcification respectively.
Follow-up and outcomes
We recorded incident fatal and non-fatal CVD events for a
mean of 17 months (max. 48 months). Endpoint status was
obtained through linkage of patients with the National
Death Registry and the National Registry of Hospital
Discharge Diagnoses from January 2002 to December
2005. Database linkage was performed with a validated
probabilistic method [23–26]. In these databases, cause of
death and the indications for hospitalisation are coded
according to the International Classification of Diseases, 9
th
and 10
th revision (ICD-9, ICD-10) [27]. Correct designation
of causes of death has been established within a comparison
study with patient medical records [28].
A trained research physician abstracted all valid end-
points from these databases on the basis of ICD codes.
Fatal and non-fatal CVD events with an atherosclerotic
background were defined by ICD-9 codes as coronary heart
disease (CHD) (codes 410–414), heart failure (code 428),
peripheral arterial disease (PAOD) (codes 440, 443–444),
aortic aneurysm (code 441), cerebrovascular disease (codes
430–438), non-rheumatic valve disease (code 424), or other
forms of heart disease (e.g. cardiac dysrythmias, or
cardiomyopathy (425, 427)). Only the latter (endpoints
with codes 424) were used in the analysis for fatal and non-
fatal non-rheumatic valve endpoints. In case of multiple
valid endpoints in the same patient, cause of death
prevailed over hospital admissions or else the first hospital
discharge diagnosis was used.
Data analysis
Descriptive information of patients, imaging characteristics,
CT indications and follow-up time were evaluated for
patients from the subcohort (random sample from cohort)
and patients with cardiovascular disease (cases). We used
regression methods implemented in SPSS software (SPSS
14.0, Chicago, IL, USA) to impute missing values (<3% for
the scored imaging characteristics). All other analyses were
performed with R software, version 6.2.
Cox proportional hazard analysis was used to investigate
whether valve calcification can be used as a predictor of
CVD events and non-rheumatic valve disease in particular.
Apart from crude associations, the hazard ratios were also
adjusted for age, sex, indication for CT and type of medical
hospital in which the CTwas performed (tertiary/secondary).
Table 2 Definitions used for visual grading of coronary and aortic calcification on routine diagnostic Chest CT
Grades
Finding Absent Mild Moderate Severe
Coronary calcification
(LM, LAD, LCX, RCA)
a
none ≤5 calcified foci or 1
calcification extending
over≥2 slices
>5calcified foci or 2
calcification extending
over≥2 slices
>6 calcified foci and≥3
calcification extending
over≥2 slices
Aortic and supra aortic
calcification
none ≤4 calcified foci or 1
calcification extending
over≥3 slices
>4 calcified foci or 2
calcification extending
over≥3 slices
calcified aorta covering
multiple segments
Note that this table needs to be interpreted as a guideline. Clinical experience of a radiologist is essential to assign points
aLM left main; LAD left anterior descending; LCX left circumflex; RCA right coronary artery
Table 1 Definitions used for visual grading of valve calcification on routine diagnostic Chest CT
Grades
Finding 0 1 2
Aortic valve calcification none One small calcification or linear calcification
of one leaflet
Linear calcification on two or three leaflets
Mitral valve calcification none One small calcification or linear calcification
of one leaflet
Linear calcification on two leaflets
Annular calcification mitral valve none Presence of annular calcification
966 Eur Radiol (2011) 21:963–973Interaction terms were included in the model to test whether
imaging characteristics (valve calcification￿ section thickness
(continuous), calcification ￿ use of contrast agent (yes/no),
calcification ￿imaging quality (bad, moderate, good), calcifi-
cation ￿ age (continuous) and calcification gender (male/
female)) modified the associations. Furthermore, survival
curves of the strongest predictors were presented to visually
illustrate the effect of the adjusted hazard ratios on the
occurrenceofCVD.Thecurvesshowtheobservedproportion
of patients being free of CVD events during follow-up per
stratum of the heart valve score. Finally, a sub-analysis was
performed to investigate whether the predictive value of
calcified heart valves for future CVD events attenuated when
additional commonly used atherosclerotic markers were
included in the model. In this analysis, the adjusted hazard
ratios were additionally corrected for calcification in aorta
and/or coronary arteries.
All hazard ratios were modified based on robust variance
estimates. These adaptations were carried out with the
method according to Prentice in which all subcohort
members are equally weighted [17]. This method has been
shown to resemble most closely estimates from a full-
cohort analysis [18].
Results
A total of 121 subjects (44 out of 559 cases (7.9%), and 77
out of 1285 subjects from the subcohort (6.0%)) were
excluded from analyses because CTs could not be retrieved
from hospital CT databases. Table 3 presents descriptive
information on patient and imaging characteristics: The
mean age of the patients from the subcohort was 61.5 years
and 58% were male. The overall prevalence in the
Fig. 2 Image examples. Upper left image shows two affected leaflets of the aortic valve. The upper right shows one calcified leaflet of the aortic
valve. The lower left image shows annular calcification of the mitral valve and the lower right image shows an affected leaflet of the mitral valve
Eur Radiol (2011) 21:963–973 967subcohort patients of aortic valve, mitral valve and mitral
annular calcification was respectively 27%, 9% and 12%.
The proportion of moderately or severely affected coronary
arteries was 43% and 31% for the aorta in subcohort
patients. A total of 515 patients experienced a cardiovas-
cular event during follow-up (for specification according
ICD codes see Appendix). With regard to the cases the
proportions of calcified heart valves, coronary arteries and
aorta were all higher. Cases were also older (mean: 68 years)
and were more often male (65%).
Table 4 shows that the risk of a CVD event increased
with an increase in the stratum of valve calcification. After
adjustment for age, sex, CT indication and type of referral
centre the hazard ratio for 1 affected aortic valve leaflet was
no longer significant (HR 1.18, 95% CI 0.87–1.61).
However, with two or three aortic leaflets affected, the risk
doubled (HR 2.03, 95% CI 1.48–2.78). When one leaflet of
the mitral valve was affected, the risk increased 1.83-fold
(95% CI 1.26–2.64) and 2.08-fold (95% CI 1.04–4.19)
when two mitral valve leaflets were affected. Annular
calcification increased the risk during follow-up with 53%
(HR 1.53, 95% CI 1.13–2.08). Figures 3 and 4 visually
present the prognostic effect of aortic and mitral valve
calcification adjusted for age, sex, imaging indication and
General information Subcohort(n=1208) CVD cases(n=515)
Male, [%] 58 65
Age, y [SD] 61.5 (40–96) 67.9 (40–96)
Follow-up, days [SD] 620 (1–1460) 322 (1–1369)
Academic referral centre, [%] 77 77
Use of contrast agent [%] 68 67
Image quality, [%]
Good 72 74
Moderate 24 24
Bad 3 2
Indication category, [%]
(1)Lung disease 37 47
(3)Haematological malignancies 11 6
(4)Mediastinal abnormalities 11 8
(5)Ruled-out pulmonary malignancy
a 24 21
(6)Pulmonary emboli 6 8
(8)Other indications 11 10
Thoracic aorta calcification
None 39 18
Mild 30 25
Moderate 19 33
Severe 12 24
Coronary arteries calcification
None 33 12
Mild 24 22
Moderate 25 29
Severe 18 37
Aortic valve calcification, [%]
None 72 53
Calcification on one leaflet 16 20
Calcification on two or three leaflets 11 27
Mitral valve calcification, [%]
None 91 82
Calcification on one leaflet 7 14
Calcification on two leaflets 2 4
Presence of annular calcification mitral valve [%] 12 20
Table 3 Baseline characteristics
aPulmonary mass, which is proven
to be non-malignant
Values are means [SD] or
proportions
968 Eur Radiol (2011) 21:963–973referral centre. The proportion of patients with a severely
calcified aorta or mitral valve who suffered a CVD event
within 3 years was 5.5% and 7%, respectively. Linearly
extrapolated to more widely used 10-year risk predictions,
these proportions would be 18% and 23%. No statistically
significant interactions were found between the valve and
annular scores and section thickness (range p=0.27–0.30),
the use of intravenous contrast medium (range p=0.13–
0.27), imaging quality (range p=0.11–0.92), age (range p=
0.13–0.69) or gender(range p=0.42–0.90).
Looking specifically at the relationship between inci-
dentally detected valve calcification and the occurrence of
non-rheumatic valve disease (n=43) we could demonstrate
strongly increased hazard ratios, yet the pattern of the
associations was the same (Table 5). For a moderately
affected aortic valve the risk increased 2.40-fold (95% CI
0.78–7.53). When the aortic valve was severely affected the
risk increased 14.57-fold (95% CI 5.19–40.53). The
Hazard ratios (95% CI)
Crude Adjusted model
a
Aortic valve calcification
None 1 1
One affected leaflet 1.79 (1.36–2.36) 1.18 (0.87–1.61)
Two or three affected leaflets 3.32 (1.83–4.96) 2.03 (1.48–2.78)
Mitral valve calcification
None 1 1
One affected leaflet 2.66 (1.89–3.75) 1.83 (1.26–2.64)
Two affected leaflets 3.46 (1.82–6.37) 2.08 (1.04–4.19)
Mitral annular calcification
None 1 1
Presence 2.11(1.59–2.81) 1.53 (1.13–2.08)
Table 4 Risk of any CVD event
(n=515) associated with
increasing calcified valve score
in clinical care patients
undergoing routine diagnostic
chest CT
CVD cardiovascular disease. CI
confidence interval
aAdjusted model: hazard ratio’s
adjusted for age, sex, imaging
indication, referral centre
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Fig. 4 Proportion of patients free of cardiovascular event according
the mitral valve score adjusted for age, sex, imaging indication,
referral centre. The dotted line is included as an example and indicates
the proportion of severely affected patients free of cardiovascular
events after 3 years’ follow-up
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Fig. 3 Proportion of patients free of cardiovascular events according
the aortic valve score adjusted for age, sex, imaging indication,
referral centre. The dotted line is included as an example and indicates
the proportion of severly affected patients free of cardiovascular
events after 3 years of follow-up
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respectively 3.84 (95% CI 1.77–8.34) and 8.78 (95% CI
2.33–33.3). The presence of mitral annular calcification
increased the risk with a factor 2.43 (95% CI 1.18–4.98).
Note however that for lack of power, these associations
were not visually presented or further adjusted in the
prospective sub-analysis.
Sub-analysis
When coronary and aortic calcification were included in
the models for any CVD event, the hazard ratio for a
moderately affected aortic valve decreased to 0.96 (95%
CI 0.70–1.32) and for a severely affected aortic valve it
decreased to 1.46 (95% CI 1.04–2.06). For the mitral
valve these ratios became 1.57 (95% CI 1.08–2.28) and
1.79 (95% CI 0.85–3.76), respectively. The corrected
hazard ratio for mitral annular calcification was 1.19
(95%CI 0.86–1.66).
Discussion
In this study, we examined whether calcification of the
aortic valve, mitral valve and mitral annulus, inciden-
tally detected on routine diagnostic chest CTs, could be
used as predictors for CVD events and non-rheumatic
valve abnormalities in particular. Furthermore we inves-
tigated whether these image characteristics remained
prognostically relevant when they were modelled with
commonly used predictive coronary and aortic calcifi-
cation [14–16, 29, 30]. We found that, within a 95%
confidence range, valve and annular calcification were
independent predictors of CVD events. Considering the
anatomical basis, the strongest associations were found for
future valve abnormalities. A sub-analysis showed that
these image characteristics only partly lost their prognostic
capacity for CVD when jointly modelled with coronary
and aortic calcification. Imaging parameters (slice thick-
ness, use of intravenous contrast agents, or quality of the
CT images), age or sex did not significantly modify the
associations found for valve calcification in relation to
future CVD events. This indicates that additional scoring
of valve and annular calcification could provide a valuable
contribution to the prediction of CVD events with hitherto
commonly used atherosclerotic image characteristics on
chest CT.
Millions of diagnostic CT examinations are made every
year and their usage is still increasing because of the
evolving quality of the CT images and the aging population
[31]. An inevitable side-effect of this process is the
increased number of incidentally detected subclinical image
characteristics. Using this information for prognostic
purposes is attractive as it can be freely abstracted from
existing imaging data and comes with no extra exposure to
ionising radiation. However, longitudinal studies, such as
this one, are needed to expose the natural course of these
findings and to demonstrate any (or lack of) relationship
with future events. Ultimately, such studies can help in
composing an evidence based approach to reporting
incidental subclinical findings.
The prevalence of valve calcification in our study was
27% for AVC, 9% for MVC and 12% for MAC. These
numbers are comparable to other studies, where the
prevalence was reported to be 13–31% [9, 10, 19]f o r
AVC, 9% for MVC[20]a n d6 –14% for MAC [6, 9, 10]. In
this study we also demonstrated a relationship between
the investigated image characteristics and CVD events.
Compared with other studies, which were mainly con-
ducted in asymptomatic elderly populations, our study
Hazard ratios (95% CI)
Crude Adjusted model
a
Aortic valve calcification
None 1 1
One affected leaflet 2.62 (0.96–7.13) 2.40 (0.78–7.53)
Two or three affected leaflets 16.27 (7.85–33.69) 14.57 (5.19–40.53)
Mitral valve calcification
None 1 1
One affected leaflet 5.17 (2.42–11.0) 3.84 (1.77–8.34)
Two affected leaflets 11.27 (4.02–34.40) 8.78 (2.33–33.13)
Mitral annular calcification
None 1 1
Presence 3.15 (1.62–6.51) 2.43(1.18–4.98)
Table 5 Risk of non-rheumatic
valve disease (n=43) associated
with increasing calcified valve
score in clinical care patients
undergoing routine diagnostic
chest CT
CVD cardiovascular disease. CI
confidence interval
aAdjusted model: hazard ratios
adjusted for age, sex, imaging indi-
cation, referral centre
970 Eur Radiol (2011) 21:963–973demonstrates these associations in a clinical care popula-
tion. Another difference is that we scored incidental valve
calcification on a very heterogeneous set of routinely
made diagnostic chest CTs, instead of the transthoracic or
transoesophageal echocardiography mainly used in other
studies. This study demonstrates how incidentally
detected CT image characteristics (simply scored with
minimal extra reviewing time) can be used in daily
clinical care for prognostic purposes. The results provide
an additional means of improving the identification of
high-risk patients, who can benefit from timely preventa-
tive measures [11]
Table 4 shows that ancillary valve calcification is an
independent predictor of CVD events after correction for
predictors readily available to radiologists. These results are
in keeping with previous literature investigating aortic
valve calcifications[32] and provide practical benefits
compared with hitherto widely used atherosclerotic imaging
characteristics (e.g. aortic and coronary calcification) as
valve calcification can be scored very simply and quickly.
However we would also like to stress that one image
characteristic does not have to exclude another in the
prediction of CVD: the sub-analysis showed that the
prognostic effect of ancillary valve calcification did not
attenuate completely when jointly modelled with coronary
and aortic calcification. This could mean that predictions of
CVD improve (in terms of accuracy) when those image
characteristics are incorporated into one prediction model
for CVD events. Note however that future research
including other statistical model performance tests should
confirm this.
This study has also some potential limitations. No
clinical information from patients’ medical records was
available, which could have influenced the exclusion of
patients already known with cardiovascular disease as we
could only exclude patients based on their CT report.
However, we excluded approximately 16% of patients from
the baseline cohort based on information from CT reports
and this is largely in line with the overall prevalence of
symptomatic CVD in the general US population of whites
(11.2%) [33], indicating that this was unlikely to have
affected our study population significantly. Clinical infor-
mation from medical records might also be used to further
adjust the hazard ratios: it is known that chronic conditions
such as diabetes, renal dysfunction and metabolic syndrome
[34–37]affect the incidence of both CVD and valve
calcifications. Despite its potential effect[38], we did not
seek to collect data on ethnicity. However, as this research
is aimed at routine radiological care, where information
about traditional risk factors is often unavailable, these
omissions are representative of routine radiological prac-
tice. The additive nature of the ‘radiological red flags’ that
may result from the clinical implementation of lessons
learnt from this research may cause the identification of at-
risk patients whom have already been identified by
referring clinicians as being at risk. Such double identifi-
cation of at risk patients on the basis of gratis (without extra
radiation exposure) radiological information would not
have any negative consequence for patients themselves
and might serve as reinforcement for referring clinicians in
cases where patients had already received preventative care
(e.g. referring clinicians may verify whether the ‘red-
flagged’ patient is receiving optimal preventative care in
such instances).
Conclusion
The PROVIDI study provides a new approach to employing
freely available and potentially valuable prognostic informa-
tion extrapolated from routine diagnostic imaging. This
particular study showed that ancillary AVC, MVC and
MAC, detected on routine care, diagnostic chest CT in a
clinical care population, can be used by radiologists to predict
cardiovascular events. Ultimately, prognostic information can
be implemented in CT reports. Note that the impact of
providing this information on risk stratification and following
preventative measures should be investigated in another
study.
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